1,7-dimethylxanthinePapers
Indexed under 1,7-dimethylxanthine in PubMed's chemical list
- papers
- 104
Newest first
1 to 50 of 104Caffeine metabolic phenotypes and hypertension risk: Urinary paraxanthine-to-caffeine ratio threshold and mediating pathways in NHANES.
Nutrition, metabolism, and cardiovascular diseases2026PMID 41549015
Body fat percentage is a key factor in elevated plasma levels of caffeine and its metabolite in women.
PeerJ2025PMID 40511376
Paraxanthine provides greater improvement in cognitive function than caffeine after performing a 10-km run.
Journal of the International Society of Sports Nutrition2024PMID 38725238
Simultaneous analysis of caffeine and paraxanthine provides potentially useful indexes in the treatment of acute caffeine intoxication.
The Journal of toxicological sciences2024PMID 39358234
A purine derivative, paraxanthine, promotes cysteine uptake for glutathione synthesis.
Journal of pharmacological sciences2023PMID 36522121
Maternal caffeine intake and DNA methylation in newborn cord blood.
The American journal of clinical nutrition2022PMID 34669932
Evaluation of CYP1A2 activity: Relationship between the endogenous urinary 6-hydroxymelatonin to melatonin ratio and paraxanthine to caffeine ratio in dried blood spots.
Clinical and translational science2022PMID 35338582
Caffeine, Paraxanthine, Theophylline, and Theobromine Content in Human Milk.
Nutrients2022PMID 35683994
Determination of caffeine, paraxanthine, theophylline and theobromine in premature infants by HILIC-MS/MS.
Bioanalysis2022PMID 36825935
Association Between Maternal Caffeine Consumption and Metabolism and Neonatal Anthropometry: A Secondary Analysis of the NICHD Fetal Growth Studies-Singletons.
JAMA network open2021PMID 33764424
The determination of the Paraxanthine/Caffeine ratio as a metabolic biomarker for CYP1A2 activity in various human matrices by UHPLC-ESIMS/MS.
Talanta2021PMID 34364467
Acute Paraxanthine Ingestion Improves Cognition and Short-Term Memory and Helps Sustain Attention in a Double-Blind, Placebo-Controlled, Crossover Trial.
Nutrients2021PMID 34836235
Dose-Response of Paraxanthine on Cognitive Function: A Double Blind, Placebo Controlled, Crossover Trial.
Nutrients2021PMID 34960030
Association of caffeine and related analytes with resistance to Parkinson disease among LRRK2 mutation carriers: A metabolomic study.
Neurology2020PMID 32999056
Caffeine and paraxanthine in aquatic systems: Global exposure distributions and probabilistic risk assessment.
The Science of the total environment2018PMID 28892846
Pregnancy-induced changes in the pharmacokinetics of caffeine and its metabolites.
Journal of clinical pharmacology2016PMID 26358647
Establishing population distribution of drug-metabolizing enzyme activities for the use of salivary caffeine as a dynamic liver function marker in a Singaporean Chinese population.
Biopharmaceutics & drug disposition2016PMID 26862045
Serum caffeine and paraxanthine concentrations and menstrual cycle function: correlations with beverage intakes and associations with race, reproductive hormones, and anovulation in the BioCycle Study.
The American journal of clinical nutrition2016PMID 27225433
Genome-wide association study of caffeine metabolites provides new insights to caffeine metabolism and dietary caffeine-consumption behavior.
Human molecular genetics2016PMID 27702941
Paraxanthine/Caffeine Concentration Ratios in Hair: An Alternative for Plasma-Based Phenotyping of Cytochrome P450 1A2?
Clinical pharmacokinetics2015PMID 25603821
Maternal serum paraxanthine during pregnancy and offspring body mass index at ages 4 and 7 years.
Epidemiology (Cambridge, Mass.)2015PMID 25643099
Urine excretion of caffeine and select caffeine metabolites is common in the U.S. population and associated with caffeine intake.
The Journal of nutrition2015PMID 25833779
Analysis of caffeine and paraxanthine in human saliva with ultra-high-performance liquid chromatography for CYP1A2 phenotyping.
Journal of chromatography2015PMID 26038236
Does volumetric absorptive microsampling eliminate the hematocrit bias for caffeine and paraxanthine in dried blood samples? A comparative study.
Analytica chimica acta2015PMID 26041521
Simultaneous multiplexed quantification of caffeine and its major metabolites theobromine and paraxanthine using surface-enhanced Raman scattering.
Analytical and bioanalytical chemistry2015PMID 26345445
Second-Trimester Maternal Serum Paraxanthine, CYP1A2 Activity, and the Risk of Severe Preeclampsia.
Obstetrics and gynecology2015PMID 26348183
An optimized and validated SPE-LC-MS/MS method for the determination of caffeine and paraxanthine in hair.
Talanta2015PMID 26452792
Maternal Caffeine Intake During Pregnancy and Child Cognition and Behavior at 4 and 7 Years of Age.
American journal of epidemiology2015PMID 26585526
The effect of single- and multiple-dose etravirine on a drug cocktail of representative cytochrome P450 probes and digoxin in healthy subjects.
Journal of clinical pharmacology2014PMID 24165884
Comparison of maternal and fetal blood levels of caffeine and its metabolite. A pilot study.
Ginekologia polska2014PMID 25118500
Psychostimulant pharmacological profile of paraxanthine, the main metabolite of caffeine in humans.
Neuropharmacology2013PMID 23261866
High-sensitivity liquid chromatography-tandem mass spectrometry for the simultaneous determination of five drugs and their cytochrome P450-specific probe metabolites in human plasma.
Journal of chromatography2012PMID 22483397
Measurement of CYP1A2 activity: a focus on caffeine as a probe.
Current drug metabolism2012PMID 22554278
Changes in CYP1A2 activity in humans after 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) administration using caffeine as a probe drug.
Drug metabolism and pharmacokinetics2012PMID 22673010
Pharmacokinetics and metabolism of natural methylxanthines in animal and man.
Handbook of experimental pharmacology2011PMID 20859793
Pharmacokinetics of caffeine in plasma and saliva, and the influence of caffeine abstinence on CYP1A2 metrics.
The Journal of pharmacy and pharmacology2011PMID 21827488
Effects of paraxanthine and caffeine on sleep, locomotor activity, and body temperature in orexin/ataxin-3 transgenic narcoleptic mice.
Sleep2010PMID 20614853
Caffeine and paraxanthine HPLC assay for CYP1A2 phenotype assessment using saliva and plasma.
Biomedical chromatography2010PMID 20853468
Influence of genetic polymorphisms, smoking, gender and age on CYP1A2 activity in a Turkish population.
Pharmacogenomics2009PMID 19450128
Effect of sodium tanshinone II A sulfonate on the activity of CYP1A2 in healthy volunteers.
Xenobiotica; the fate of foreign compounds in biological systems2009PMID 19534587
Effects of gender and moderate smoking on the pharmacokinetics and effects of the CYP1A2 substrate tizanidine.
European journal of clinical pharmacology2008PMID 17955229
Interaction profile of armodafinil with medications metabolized by cytochrome P450 enzymes 1A2, 3A4 and 2C19 in healthy subjects.
Clinical pharmacokinetics2008PMID 18076219
Assessing caffeine exposure in pregnant women.
The British journal of nutrition2008PMID 18331663
In vivo evaluation of CYP1A2, CYP2A6, NAT-2 and xanthine oxidase activities in a Greek population sample by the RP-HPLC monitoring of caffeine metabolic ratios.
Biomedical chromatography2007PMID 17221922
Appropriate phenotyping procedures for drug metabolizing enzymes and transporters in humans and their simultaneous use in the "cocktail" approach.
Clinical pharmacology and therapeutics2007PMID 17259951
Caffeine metabolites in umbilical cord blood, cytochrome P-450 1A2 activity, and intrauterine growth restriction.
American journal of epidemiology2006PMID 16641310
Awareness and use of caffeine by athletes competing at the 2005 Ironman Triathlon World Championships.
International journal of sport nutrition and exercise metabolism2006PMID 17240785
Population pharmacokinetics of caffeine and its metabolites theobromine, paraxanthine and theophylline after inhalation in combination with diacetylmorphine.
Basic & clinical pharmacology & toxicology2005PMID 15667599
Cyp2a6 is a principal enzyme involved in hydroxylation of 1,7-dimethylxanthine, a main caffeine metabolite, in humans.
Drug metabolism and disposition: the biological fate of chemicals2005PMID 15980104
Assessment of CYP1A2 activity in clinical practice: why, how, and when?
Basic & clinical pharmacology & toxicology2005PMID 16128905